Reducing State Conflicts between Network Motifs Synergistically Enhances Cancer Drug Effects and Overcomes Adaptive...

Area of Science:

• Systems Biology
• Computational Biology
• Cancer Research

Background:

• Cancer therapy aims to induce apoptosis but faces challenges like drug resistance due to complex molecular networks and heterogeneous responses.
• Single-target drugs often induce adaptive responses, limiting their effectiveness in cancer treatment.

Purpose of the Study:

• To investigate how targeted drug perturbations affect molecular regulatory networks and lead to heterogeneous cancer cell responses.
• To develop a computational approach for identifying synergistic drug targets that can overcome adaptive drug resistance.

Main Methods:

• Utilized Boolean network modeling to represent cellular response dynamics under target node perturbation.
• Developed an algorithm to identify synergistic combinatorial targets by analyzing molecular regulatory networks.
• Validated the approach using exemplary network models and a gastric cancer model.

Main Results:

• Demonstrated that targeted drug perturbations can trigger state conflicts in multi-stable motifs, causing heterogeneous drug responses.
• Identified that regulating interconnecting molecules can minimize heterogeneous responses and overcome drug resistance.
• Showcased that the algorithm-identified targets effectively drive networks to desired states, outperforming other control theories.

Conclusions:

• A novel computational approach can identify synergistic drug targets to overcome adaptive resistance in cancer.
• Targeting specific interconnecting molecules offers a strategy to enhance cancer drug efficacy and improve patient outcomes.